英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:

moiety    
n. 一半,一部分,应得之份

一半,一部分,应得之份

moiety
n 1: one of two (approximately) equal parts [synonym: {moiety},
{mediety}]
2: one of two basic subdivisions of a tribe

Moiety \Moi"e*ty\ (moi"[-e]*t[y^]), n.; pl. {Moieties}
(moi"[-e]*t[i^]z). [F. moiti['e], L. medietas, fr. medius
middle, half. See {Mid}, a., and cf. {Mediate}, {Mediety}.]
1. One of two equal parts; a half; as, a moiety of an estate,
of goods, or of profits; the moiety of a jury, or of a
nation. --Shak.
[1913 Webster]

The more beautiful moiety of his majesty's subject.
--Addison.
[1913 Webster]

2. An indefinite part; a small part. --Shak.
[1913 Webster]


Residue \Res"i*due\ (r?z"?-d?), n. [F. r['e]sidu, L. residuum,
fr. residuus that is left behind, remaining, fr. residere to
remain behind. See {Reside}, and cf. {Residuum}.]
1. That which remains after a part is taken, separated,
removed, or designated; remnant; remainder.
[1913 Webster]

The residue of them will I deliver to the sword.
--Jer. xv. 9.
[1913 Webster]

If church power had then prevailed over its victims,
not a residue of English liberty would have been
saved. --I. Taylor.
[1913 Webster]

2. (Law) That part of a testeator's estate wwhich is not
disposed of in his will by particular and special legacies
and devises, and which remains after payment of debts and
legacies.
[1913 Webster]

3. (Chem.) That which remains of a molecule after the removal
of a portion of its constituents; hence, an atom or group
regarded as a portion of a molecule; a {moiety} or
{group}; -- used as nearly equivalent to {radical}, but in
a more general sense.
[1913 Webster PJC]

Note: The term radical is sometimes restricted to groups
containing carbon, the term residue and {moiety} being
applied to the others.
[1913 Webster]

4. (Theory of Numbers) Any positive or negative number that
differs from a given number by a multiple of a given
modulus; thus, if 7 is the modulus, and 9 the given
number, the numbers -5, 2, 16, 23, etc., are residues.
[1913 Webster]

Syn: Rest; remainder; remnant; balance; residuum; remains;
leavings; relics.
[1913 Webster]

118 Moby Thesaurus words for "moiety":
allotment, allowance, ashram, big end, bigger half, bisection, bit,
bite, body, budget, butt, caste, chip, chunk, clan, class, clip,
clipping, collop, colony, commission, commonwealth, commune,
community, contingent, crumb, cut, cutting, deal, destiny,
dividend, division, dole, dollop, economic class, end,
endogamous group, equal share, equidistance, extended family,
family, fate, fifty percent, fifty-fifty, fragment, gens, gob,
gobbet, half, half-and-half, halfway house, halver, helping,
hemisphere, hunk, interest, kinship group, lot, lump, measure,
mediety, meed, member, mess, mid-distance, midcourse,
middle distance, midway, modicum, morsel, nuclear family, order,
parcel, paring, part, particle, percentage, phratria, phratry,
phyle, piece, portion, proportion, quantum, quota, rake-off,
rasher, ration, scoop, scrap, section, segment, semicircle,
semisphere, settlement, shard, share, shaving, shiver, shred,
slice, sliver, small share, smithereen, snack, snatch, snip,
snippet, social class, society, splinter, stake, stitch, stock,
stump, subcaste, tatter, totem


请选择你想看的字典辞典:
单词字典翻译
moiety查看 moiety 在百度字典中的解释百度英翻中〔查看〕
moiety查看 moiety 在Google字典中的解释Google英翻中〔查看〕
moiety查看 moiety 在Yahoo字典中的解释Yahoo英翻中〔查看〕





安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Bempedoic Acid and Cardiovascular Outcomes in Statin . . .
    The risk of death from cardiovascular causes, nonfatal stroke, or nonfatal myocardial infarction (the first key secondary end point) was 15% lower with bempedoic acid than with placebo, and the
  • Bempedoic Acid Reduces Major Adverse Cardiovascular Events . . .
    Tip for Patients: For patients who cannot take a statin, bempedoic acid (Nexletol) is an alternative to statin therapy for prevention of cardiovascular disease in high-risk patients without significant liver or kidney disease
  • Nexletol shows CLEAR benefit in cardiovascular outcome trial
    New data for Esperion’s cholesterol lowering daily pill Nexletol, used when statins are not working in people at risk of a heart attack, could inject some momentum into the drug’s slow rollout
  • Esperion Announces New Data from CLEAR Outcomes Highlighting . . .
    The most common adverse reactions in the cardiovascular outcomes trial for NEXLETOL at an incidence of ≥2% and 0 5% greater than placebo were hyperuricemia, renal impairment, anemia, elevated liver enzymes, muscle spasms, gout, and cholelithiasis
  • NEXLIZET® NEXLETOL® CLEAR Outcomes Trial Information
    The most common adverse reactions in the cardiovascular outcomes trial for bempedoic acid, a component of NEXLIZET and NEXLETOL, at an incidence of ≥2% and 0 5% greater than placebo were hyperuricemia, renal impairment, anemia, elevated liver enzymes, muscle spasms, gout, and cholelithiasis
  • U. S. FDA Approves Broad New Labels for NEXLETOL® and NEXLIZET . . .
    ANN ARBOR, Mich , March 22, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the United States Food and Drug Administration (FDA) has approved broad new label expansions for NEXLETOL ® (bempedoic acid) Tablets and NEXLIZET ® (bempedoic acid and ezetimibe) Tablets based on positive CLEAR Outcomes data that include indications for cardiovascular risk reduction and expanded
  • In Brief: Cardiovascular Outcomes with Bempedoic Acid (Nexletol)
    CONCLUSION ― In one large clinical trial in statinintolerant patients who had or were at high-risk for cardiovascular disease, the oral adenosine triphosphate- citrate lyase (ACL) inhibitor bempedoic acid (Nexletol) modestly reduced the risk of a 4-component composite of major adverse cardiovascular events (MACE) compared to placebo
  • LABEL - accessdata. fda. gov
    In the cardiovascular outcomes trial, in which 7,001 patients were exposed to NEXLETOL and 6,964 patients were exposed to placebo for a median of 3 1 years [see Clinical Studies, (14 1)], adverse reactions led to discontinuation of treatment in 11% of NEXLETOL-treated patients and 10% of placebo-treated patients
  • CLEAR Outcomes: Bempedoic Acid Reduces Cardiovascular Events . . .
    The non-statin lipid-lowering medication bempedoic acid (Nexletol®) has demonstrated a significant reduction in the risk of cardiovascular events in a large outcomes study of statin-intolerant patients treated for primary or secondary cardiovascular prevention
  • Nexletol (Bempedoic acid) for Heart Disease
    Nexletol is indicated as an adjunct therapy to diet and maximally-tolerated statin therapy Nexletol is also referred to by its drug name, bempedoic acid Nexletol is a member of the adenosine triphosphate-citrate lyase (ACL) inhibitor class of drugs It is believed to work in cases of heart disease by inhibiting cholesterol production in the





中文字典-英文字典  2005-2009